⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11105757 | 0.97 | — | — | |
| SCHEMBL4954124 | 0.84 | — | — | |
| SCHEMBL710563 | 0.84 | — | — | |
| SCHEMBL3869487 | 0.82 | — | — | |
| SCHEMBL3459429 | 0.81 | — | — | |
| SCHEMBL4954547 | 0.81 | — | — | |
| SCHEMBL557960 | 0.81 | — | — | |
| SCHEMBL10354611 | 0.79 | — | — | |
| SCHEMBL3471566 | 0.78 | — | — | |
| SCHEMBL3200848 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1214586-B1 | IMPLANTABLE GLUCOSE SENSOR | OXYGEN BIOTHERAPEUTICS INC (US) | 2010-03-24 | — | — | EP | claimed |
| US-6815186-B2 | COMPRISES GLUCOSE OXIDASE EMULSION WITH PERFLUOROCARBON WHICH IS USED WITH MINIATURE POLAROGRAPHIC DEVICE; GELS | IMPLANTED BIOSYSTEMS, INC. | 2004-11-09 | — | — | US | claimed |
| WO-2001020019-A9 | IMPLANTABLE GLUCOSE SENSOR | IMPLANTED BIOSYSTEMS INC (US) | 2002-08-29 | — | — | WO | claimed |
| EP-1214586-A2 | IMPLANTABLE GLUCOSE SENSOR | Implanted Biosystems, Inc. (US) | 2002-06-19 | — | — | EP | claimed |
| US-20020068860-A1 | Implantable glucose sensor | IMPLANTED BIOSYSTEMS, INC. | 2002-06-06 | — | — | US | claimed |
| US-6343225-B1 | SENSOR PROVIDING OXYGEN RESERVOIR IN INTIMATE CONTACT WITH OXIDATIVE ENZYME BY MAKING EMULSION OF ENZYME AND COMPOUND IN WHICH OXYGEN IS EXTREMELY SOLUBLE AND STABILIZING BY CROSSLINKING MIXTURE TO FORM GEL | IMPLANTED BIOSYSTEMS, INC. | 2002-01-29 | — | — | US | claimed |
| WO-2001020019-A2 | IMPLANTABLE GLUCOSE SENSOR | IMPLANTED BIOSYSTEMS, INC. (US) | 2001-03-22 | — | — | WO | claimed |
| US-5824703-A | INSTILLING A LIQUID MIXTURE OF HIGH VAPOR PRESSURE PERFLUOROCARBON THROUGH THE TRACHEA OF A MAMMAL | SYNTHETIC BLOOD INTERNATIONAL, INC. (US) | 1998-10-20 | — | — | US | claimed |
| US-5674913-A | INSTILLING A PERFLUOROCHEMICAL LIQUID INTO THE TRACHEA TO FILL THE ALVEOLAR SACS TO ENABLE NORMAL BREATHING; REMOVAL OF BREATHING-ASSISTING EQUIPMENT; NO INDUCING OF HYPERINFLATED LUNG SYNDROME; SURFACTANT-DEFICIENT | SYNTHETIC BLOOD INTERNATIONAL, INC. (US) | 1997-10-07 | — | — | US | claimed |
| EP-0758886-A1 | USE OF PERFLUOROCARBONS FOR ASSISTING NORMAL BREATHING IN MAMMALS HAVING LUNG DISORDERS | SYNTHETIC BLOOD INTERNATIONAL, INC. (US) | 1997-02-26 | — | — | EP | claimed |
| WO-1995031191-A1 | USE OF PERFLUOROCARBONS FOR ASSISTING NORMAL BREATHING IN MAMMALS HAVING LUNG DISORDERS | SYNTHETIC BLOOD INTERNATIONAL, INC. (US) | 1995-11-23 | — | — | WO | claimed |
| US-9554993-B2 | Pulmonary delivery particles comprising an active agent | NOVARTIS AG (CH) | 2017-01-31 | — | — | US | disclosed |
| US-8168223-B1 | Engineered particles and methods of use | NOVARTIS PHARMA AG (CH) | 2012-05-01 | — | — | US | disclosed |
| US-20100272823-A1 | PULMONARY DELIVERY PARTICLES COMPRISING WATER INSOLUBLE OR CRYSTALLINE ACTIVE AGENTS | NOVARTIS PHARMA AG (CH) | 2010-10-28 | — | — | US | disclosed |
| EP-1019022-B2 | METHOD FOR FORMING A POWDER COMPRISING PERFORATED MICROPARTICLES | NOVARTIS AG (CH) | 2010-07-28 | — | — | EP | disclosed |
| US-5861175-A | ADMINISTERING FOR CUSHIONING AND LUBRICATION OF JOINTS; ARTHRIRIS, RHEUMATIC DISEASES | ALLIANCE PHARMACEUTICAL CORP. (US) | 1999-01-19 | — | — | US | disclosed |
| US-5824703-A | INSTILLING A LIQUID MIXTURE OF HIGH VAPOR PRESSURE PERFLUOROCARBON THROUGH THE TRACHEA OF A MAMMAL | SYNTHETIC BLOOD INTERNATIONAL, INC. (US) | 1998-10-20 | — | — | US | disclosed |
| US-5674913-A | INSTILLING A PERFLUOROCHEMICAL LIQUID INTO THE TRACHEA TO FILL THE ALVEOLAR SACS TO ENABLE NORMAL BREATHING; REMOVAL OF BREATHING-ASSISTING EQUIPMENT; NO INDUCING OF HYPERINFLATED LUNG SYNDROME; SURFACTANT-DEFICIENT | SYNTHETIC BLOOD INTERNATIONAL, INC. (US) | 1997-10-07 | — | — | US | disclosed |
| EP-0758886-A1 | USE OF PERFLUOROCARBONS FOR ASSISTING NORMAL BREATHING IN MAMMALS HAVING LUNG DISORDERS | SYNTHETIC BLOOD INTERNATIONAL, INC. (US) | 1997-02-26 | — | — | EP | disclosed |
| WO-1995031191-A1 | USE OF PERFLUOROCARBONS FOR ASSISTING NORMAL BREATHING IN MAMMALS HAVING LUNG DISORDERS | SYNTHETIC BLOOD INTERNATIONAL, INC. (US) | 1995-11-23 | — | — | WO | disclosed |